Anomalies of the CD8(+) T cell pool in haemochromatosis: HLA-A3-linked expansions of CD8(+)CD28(-) T cells

被引:62
作者
Arosa, FA [1 ]
Oliveria, L [1 ]
Porto, G [1 ]
DaSilva, BM [1 ]
Kruijer, W [1 ]
Veltman, J [1 ]
DeSousa, M [1 ]
机构
[1] SANTO ANTONIO GEN HOSP, DEPT HAEMATOL, OPORTO, PORTUGAL
关键词
haemochromatosis; CD8(+) T cells; CD28; expression; HLA-A3; iron metabolism;
D O I
10.1046/j.1365-2249.1997.d01-967.x
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The present study consists of a phenotypic and functional characterization of peripheral blood T lymphocytes in a group of 21 patients with hereditary haemochromatosis (HH), an MHC class I-linked genetic disease resulting in iron overload, and a group of 30 healthy individuals, both HLA-phenotyped. The HH patients studied showed an increased percentage of CD8(+) CD28(-) T cells with a corresponding reduction in the percentage of CD8(+) CD28(+) T cells in peripheral blood relative to healthy blood donors. No anomalies of CD28 expression were found in the CD4(+) subset. The presence of the HLA-A3 antigen but not age accounted for these imbalances. Thus, an apparent failure of the CD8(+) CD28(+) T cell population 'to expand', coinciding with an 'expansion' of CD8(+) CD28(-) T cells in peripheral blood of HLA-A3(+) but not HLA-A3(-) HH patients was observed when compared with the respective HLA-A3-matched control group. A significantly higher percentage of HLA-DR(+) but not CD45RO(+) cells was also found within the peripheral CD8(+) T cell subset in HH patients relative to controls. Phytohaemagglutinin (PHA) stimulation of peripheral blood mononuclear cells (PBMC) for 5 days showed: (i) that CD8(+) CD28(+) T cells both in controls and HH were able to expand in vitro; (ii) that CD8(+) CD28(-) T cells decreased markedly after activation in controls but not in HH patients. Moreover, functional studies showed that CD8(+) cytotoxic T lymphocytes (CTL) from HH patients exhibited a diminished cytotoxic activity (approx. two-fold) in standard Cr-51-release assays when compared with CD8(+) CTL from healthy controls. The present results provide additional evidence for the existence of phenotypic and functional anomalies of the peripheral CD8(+) T cell pool that may underlie the clinical heterogeneity of this iron overload disease. They are of particular relevance given the recent discovery of a novel mutated MHC class I-like gene in HH.
引用
收藏
页码:548 / 554
页数:7
相关论文
共 31 条
[1]   DECREASED CD8-P56LCK ACTIVITY IN PERIPHERAL-BLOOD T-LYMPHOCYTES FROM PATIENTS WITH HEREDITARY HEMOCHROMATOSIS [J].
AROSA, FA ;
DASILVA, AJ ;
GODINHO, IM ;
TERSTEEGE, JCA ;
PORTO, G ;
RUDD, CE ;
DESOUSA, M .
SCANDINAVIAN JOURNAL OF IMMUNOLOGY, 1994, 39 (05) :426-432
[2]  
AZUMA M, 1993, J IMMUNOL, V150, P1147
[3]  
BECKER H, 1993, IMMUN INFEKT, V21, P5
[4]  
CABEDA JM, 1995, FASEB J, pA527
[5]  
CHOREMIPAPADOPOULOU H, 1994, J ACQ IMMUN DEF SYND, V7, P245
[6]   INCREASED PERCENTAGE OF CD3+, CD57+ LYMPHOCYTES IN PATIENTS WITH RHEUMATOID-ARTHRITIS - CORRELATION WITH DURATION OF DISEASE [J].
DANGEAC, AD ;
MONIER, S ;
JORGENSEN, C ;
GAO, QL ;
TRAVAGLIOENCINOZA, A ;
BOLOGNA, C ;
COMBE, B ;
SANY, J ;
REME, T .
ARTHRITIS AND RHEUMATISM, 1993, 36 (05) :608-612
[7]  
DESOUSA M, 1991, CURR STUD HEMATOL BL, V58, P171
[8]   Chagasic patients lack CD28 expression on many of their circulating T lymphocytes [J].
Dutra, WO ;
Martins-Filho, OA ;
Cancado, JR ;
PintoDias, JC ;
Brener, Z ;
Gazzinelli, G ;
Carvalho, JF ;
Colley, DG .
SCANDINAVIAN JOURNAL OF IMMUNOLOGY, 1996, 43 (01) :88-93
[9]   A novel MHC class I-like gene is mutated in patients with hereditary haemochromatosis [J].
Feder, JN ;
Gnirke, A ;
Thomas, W ;
Tsuchihashi, Z ;
Ruddy, DA ;
Basava, A ;
Dormishian, F ;
Domingo, R ;
Ellis, MC ;
Fullan, A ;
Hinton, LM ;
Jones, NL ;
Kimmel, BE ;
Kronmal, GS ;
Lauer, P ;
Lee, VK ;
Loeb, DB ;
Mapa, FA ;
McClelland, E ;
Meyer, NC ;
Mintier, GA ;
Moeller, N ;
Moore, T ;
Morikang, E ;
Prass, CE ;
Quintana, L ;
Starnes, SM ;
Schatzman, RC ;
Brunke, KJ ;
Drayna, DT ;
Risch, NJ ;
Bacon, BR ;
Wolff, RK .
NATURE GENETICS, 1996, 13 (04) :399-408
[10]  
FITZGERALD JE, 1995, J IMMUNOL, V154, P3538